This is a randomized double-blinded study of enteral iron supplementation in Very Low Birth Weight infants. The subjects will be randomized into low dose (2 mg/kg/day) and high dose (6 mg/kg/day) of daily iron supplementation. The primary outcomes are intestinal health including microbiome, inflammation, and barrier function.
Age range
1 Day – 6 Months
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in stool bacterial percentages from before to after iron supplementation
Timeframe: from baseline to 1 week and 2 weeks after iron supplementation started
Change in fecal calprotectin from before to after iron supplementation
Timeframe: from baseline to 1 week and 2 weeks after iron supplementation started
Change in urine Claudin-3 and I-FABP from before to after iron supplementation
Timeframe: from baseline to 1 week and 2 weeks after iron supplementation started